News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Reset Therapeutics Receives National Institutes of Health (NIH) Grant to Develop Novel Treatments for Narcolepsy



1/7/2013 9:19:21 AM

BURLINGAME, Calif.--(BUSINESS WIRE)--Reset Therapeutics, the leader in harnessing the power of the body’s internal clocks to discover, develop, and commercialize high-value therapeutics for a variety of disease indications, today announced that it has been awarded a five-year cooperative agreement by the National Institutes of Health (NIH) to develop a new drug to treat narcolepsy. Reset’s award includes up to $1 million in direct funding and access to contracted research services worth at least $10 million over the project’s anticipated five-year period. The award was made through the NIH Blueprint Neurotherapeutics Network, which was established in order to bridge the gap in neuroscience-related drug development between academic and industry research.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES